Ultimately, similar rules may apply to prion-like proteins (tau, α-synuclein, Amyloid-β42) responsible for highly prevalent neurodegenerative disorders with a significant impact in society: Alzheimer’s and Parkinson’s diseases. This evidence concerns the gene MAPT and Parkinson disease.